I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 6 studies | 18% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 17% ± 1% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 21% ± 3% | |
| B cell | 4 studies | 18% ± 2% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 22% ± 5% | |
| endothelial cell | 4 studies | 21% ± 3% | |
| retinal ganglion cell | 4 studies | 73% ± 25% | |
| amacrine cell | 4 studies | 37% ± 15% | |
| CD4-positive, alpha-beta T cell | 3 studies | 25% ± 6% | |
| retinal bipolar neuron | 3 studies | 32% ± 12% | |
| mucosal invariant T cell | 3 studies | 16% ± 2% | |
| epithelial cell | 3 studies | 36% ± 15% | |
| retina horizontal cell | 3 studies | 29% ± 13% | |
| retinal cone cell | 3 studies | 49% ± 20% | |
| retinal rod cell | 3 studies | 28% ± 9% | |
| Mueller cell | 3 studies | 17% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 18% ± 5% | |
| neuron | 3 studies | 38% ± 21% |
